<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gamcho-Sasim-Tang (GS-Tang) is a traditional Chinese medication, which has been successfully used in Korea for the treatment of Adamantiades-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (ABD) </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the modulation effects of GS-Tang on cytokine production from phytohaemagglutinin-stimulated peripheral blood mononuclear cells of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's patients </plain></SENT>
<SENT sid="2" pm="."><plain>ABD is a systemic <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorder</z:e> and might involve <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune dysfunction</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Cytokines involved in the regulation of inflammatory reactions and immune responses may play a role in the pathogenesis of ABD </plain></SENT>
<SENT sid="4" pm="."><plain>GS-Tang (1 mg/ml) significantly inhibited the production of proinflammatory cytokines, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta), compared to absence of GS-Tang (by 42.0+/-6.6% inhibition for TNF-alpha and 95.9+/-5.7% for IL-1 beta, P&lt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>GS-Tang also inhibited the production of IFN-gamma, immunoregulatory T helper cell type 1 cytokine, by 80.2+/-5.3% (P=0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>The inhibitory effects of GS-Tang on cytokine production showed dose-dependent manner </plain></SENT>
<SENT sid="7" pm="."><plain>Our results suggest that GS-Tang might have anti-inflammatory and immuno-regulatory effects through the cytokine modulation </plain></SENT>
</text></document>